subject: Melanoma - Drug Pipeline Analysis And Market Forecasts To 2015---aarkstore Enterprise Market [print this page] Description Description
The industry analysis specialists new report, Melanoma Disease - Drug Pipeline Analysis and Market Forecasts to 2015 is an essential source of information and analysis on the global Melanoma disease market. The report identifies the key trends shaping and driving the global Melanoma disease market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global Melanoma disease sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by team of industry experts. Estimated the global Melanoma disease market to be valued at $330m in 2008. It is forecast to grow at 14% annually for the next seven years to reach $800m by 2015. This growth is primarily attributed to the influx of new products, increase in diseased population and strong pipeline with more emerging therapies. The available treatment options are low to moderately successful in meeting the market demand. There exists a significant market potential to be tapped for any new entrant that will cater to the unmet needs.
Finds that that the emerging therapies in pipeline are expected to consolidate the market. Emerging therapies have gained a positive perception among the physicians. These novel therapies are likely to drive the drug prices high thereby resulting in increased average treatment cost. There is likely to be a significant increase in the prescription of biologics for long term maintenance as they have high specificity
Scope of the Report
The scope of the report includes:
* Annualized global Melanoma disease market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.
* Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
* Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action includes oxidative stress inducer targets Bcl-2 receptor Mitotic Inhibitor MAGE antigen Immunomodulatory effects T-cell enhancer anti-CTLA4 Peptide Viral vaccine Peptide encapsulated vaccine Combinations.
* Analysis of the current and future market competition in the global Melanoma disease market. Key market players covered are Oncolytics Biotech., Bristol-Myers Squibb, Swedish Orphan International AB Bayer Schering Pharma AG, Genta Incorporated, Schering-Plough, GlaxoSmithKline and Abraxis BioScience.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with Melanoma disease.
